Celltrion

Celltrion

World Rank (Aug-2026)
794
Market Cap (Aug-2026)
33.137 Billion USD
World Rank (Jan-05-2024)
509
Market Cap (Jan-05-2024)
35.824 Billion USD
World Rank (Jul-30-2023)
1,134
Market Cap (Jul-30-2023)
16.020 Billion USD
World Rank (Jan-07-2022)
985
Market Cap (Jan-07-2022)
21.209 Billion USD
World Rank (Jan-01-2021)
378
Market Cap (Jan-01-2021)
43.780 Billion USD
Headquarters Country
South Korea
CEO
Hyoung Ki Kim
Chairman
Jung-jin Seo
Billionaires
Seo Jung Jin
Employee Count
2,263
Employee Count as of Date
As on 2022
World Region
Asia
World Subregion
Eastern Asia
Annual Revenue in USD
2,966 Million USD
Annual Operating Income in USD
824 Million USD
Annual Net Income in USD
734 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
15,916 Million USD
Total Liabilities in USD
3,551 Million USD
Total Equity in USD
12,366 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
Biopharmaceutical
Pharmaceutical
Biotechnology
HealthCare Products
Company Website
Celltrion
Wikipedia
Wikipedia
Yahoo
Yahoo @ SouthKorea
Facebook
Facebook
Company Profile

Celltrion is a Biopharmaceutical company. The headquarters is in South Korea.

Celltrion achieved what was thought impossible by launching the world’s first “antibody biosimilar” from a country with a relatively underdeveloped pharmaceutical sector. The company has pioneered numerous uncharted areas to stellar success, which it plans to follow up by continuing its growth as a global biopharmaceutical company with unique approaches to small molecule pharmaceuticals and new businesses such as the Ubiquitous-healthcare platform business.

Annual Results Summary

CELLTRION - Yearly Results - Revenue and Net Profit - in Billion KRW:

Annual EndingRevenueOperating ProfitNet Profit
Dec-20211,911752575
Dec-20201,849712511
Dec-20191,128378297
Dec-2018982338261
Balance Sheet Summary

Total Assets as on Dec-2021 is 5,697 Billion KRW.

Total Liabilities as on Dec-2021 is 1,623 Billion KRW.

Total Equity as on Dec-2021 is 4,073 Billion KRW.

Founded Year
2002
Stock Exchange
South Korea

Share